Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity

S Bu, L Royston, T Mabanga, CA Berini… - Frontiers in …, 2024 - frontiersin.org
Introduction Growth differentiation factor 15 (GDF-15) was originally described as a stress-
induced cytokine, and a biomarker of aging and cardiovascular diseases. We hypothesized …

The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not?

AO Babalghith, HM Al-Kuraishy, AI Al-Gareeb… - Diagnostics, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is primarily caused by various forms of severe acute
respiratory syndrome coronavirus type 2 (SARS-CoV-2) variants. COVID-19 is characterized …

Growth differentiation factor 15 (GDF-15): a novel biomarker associated with poorer respiratory function in COVID-19

L Alserawan, P Peñacoba, SE Orozco Echevarría… - Diagnostics, 2021 - mdpi.com
It is essential to find new biomarkers for severity stratification of patients with coronavirus
disease (COVID-19). Growth differentiation factor 15 (GDF-15) is upregulated in pathological …

Comprehensive profiling of inflammatory factors revealed that growth differentiation factor-15 is an indicator of disease severity in COVID-19 patients

X Teng, J Zhang, Y Shi, Y Liu, Y Yang, J He… - Frontiers in …, 2021 - frontiersin.org
To systematically explore potential biomarkers which can predict disease severity in COVID-
19 patients and prevent the occurrence or development of severe COVID-19, the levels of …

[HTML][HTML] Growth differentiation factor 15 as an emerging novel biomarker in SARS-CoV-2 infection

D Parchwani, S Dholariya, CDS Katoch… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Growth differentiation factor (GDF)-15 is a member of a transforming growth
factor-β cytokine superfamily that regulates metabolism and is released in response to …

Growth differentiation factor 15 provides prognostic information superior to established cardiovascular and inflammatory biomarkers in unselected patients …

PL Myhre, C Prebensen, H Strand, R Røysland… - Circulation, 2020 - Am Heart Assoc
Background: Growth differentiation factor 15 (GDF-15) is a strong prognostic marker in
sepsis and cardiovascular disease (CVD). The prognostic value of GDF-15 in coronavirus …

Serum growth differentiation factor-15 (GDF-15) is a biomarker of cardiac manifestations in children with COVID-19

SR Ishak, MME Ganzoury, EM Fouda… - European Journal of …, 2023 - Springer
Background COVID-19 leads to severe overwhelming inflammation in some patients
mediated by various cytokines (cytokine storm) that usually leads to severe illness …

Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients

A Molfino, E Anastasi, E Assanto, L Toccini… - Internal and Emergency …, 2024 - Springer
To quantify the circulating levels of novel serum biomarkers including GDF-15, PIVKA-II,
sdLDL, suPAR, and of CRP in hospitalized COVID-19 patients compared with healthy …

Cytokine elevation in severe COVID-19 from longitudinal proteomics analysis: comparison with sepsis

T Ebihara, H Matsumoto, T Matsubara… - Frontiers in …, 2022 - frontiersin.org
Introduction Coronavirus disease 2019 (COVID-19) is a new viral disease. Uncontrolled
inflammation called “cytokine storm” is reported to contribute to disease pathogenesis as …

Coping with stress: the mitokine GDF-15 as a biomarker of COVID-19 severity

DS Ahmed, S Isnard, C Berini, J Lin, JP Routy… - Frontiers in …, 2022 - frontiersin.org
Growth differentiation factor 15 (GDF-15) is a transforming growth factor (TGF)-β superfamily
cytokine that plays a central role in metabolism regulation. Produced in response to …